Valantine Hannah

Valantine Hannah is listed in filings as Director at Pacific Biosciences of California, Inc.. This profile follows SEC Form 4 activity through Jun 4, 2026, including sale activity. Recent filings connect the profile to Pacific Biosciences of California, Inc. (PACB), BridgeBio Pharma, Inc. - Common Stock (BBIO), and CareDx, Inc. (CDNA). The current snapshot covers public activity from Jun 18, 2024 to Jun 4, 2026. Reported amounts are shown as $353.1K to $237.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.